Objectives: The size of the upper airway is smallest during sleep, at the end of expiration. This may favor upper-airway collapse in patients with obstructive sleep apnea. In the respiratory cycles preceding obstructive events during sleep, our hypothesis is that upper-airway resistance (UAR) increased earlier during expiration prior to changes occurring during inspiration.
Design: We analyzed the pharyngeal pressure-to-flow ratios in order to determine variations in UAR for both inspiration and expiration during stable respiration and the 4 consecutive breaths preceding upper-airway obstructive events in stage 2 sleep. To assess the variation of resistance throughout the within-breath period during stable respiration and the 4 breaths preceding obstructive events, results were expressed as the instantaneous resistance at fixed points 10%, 30%, 50%, 70%, and 90% of time values of inspiration and expiration. Global inspiratory and expiratory UARs during wakefulness and sleep in stable respiration were expressed by the median of instantaneous UAR values.
Setting: Tertiary-care academic medical center.
Patients: Eleven patients with moderate to severe sleep-disordered breathing.
Intervention: None.
Measurements and results: During stable respiration, both inspiratory and expiratory resistance increased during sleep, compared to values while awake. The difference between inspiratory and expiratory UAR increased when sleep deepened. During the respiratory cycle, the increase in the end-expiratory UAR occurred earlier than during inspiration; during stable respiration, UAR was much aggravated during the last three breaths preceding an obstructive event.
Conclusion: Increases in the expiratory UAR occurred earlier than during inspiration in the cycles preceding upper-airway collapse in patients with sleep apnea. This finding suggested an important role of the expiratory phase in promoting upper-airway collapse and is in accordance with the inspiratory pharyngeal instability occurring when lowering the expiratory pressure in patients with obstructive sleep apnea.